Skip to content
Home » Silgard » Page 3

Silgard

Katie Couric does a 180 and an apology. Too late.

gardasil-one-lessAfter publishing a few articles about Katie Couric‘s false balanced anti-Gardasil episode that completely ignored real science broadcast on her eponymous TV talk show, Katie, I thought I could move on to other topics in skepticism. I, and dozens of other writers on the internet, had chided, criticized and lambasted her using anecdotes from two mothers to impugn the safety of Gardasil (formally known as the HPV quadrivalent vaccine and also called Silgard in Europe), while ignoring solid science and medical research that supports the safety and effectiveness of the vaccine.

Well, today, Couric issued an apology, of sorts, regarding the episode. Her introductory paragraph, basically says it all:

Last week we devoted several segments on my TV talk show to the issues surrounding the HPV (human papillomavirus) vaccine. Learning about this relatively recent preventive measure is tremendously important, and I felt it was a subject well worth exploring. Following the show, and in fact before it even aired, there was criticism that the program was too anti-vaccine and anti-science, and in retrospect, some of that criticism was valid. We simply spent too much time on the serious adverse events that have been reported in very rare cases following the vaccine. More emphasis should have been given to the safety and efficacy of the HPV vaccines. As someone who has spent the last 15 years relaying important medical information with the goal of improving public health, it is critical to me that people know the facts.Read More »Katie Couric does a 180 and an apology. Too late.

Katie Couric doubles down on the Gardasil false balance

katie-couric-hpv

Revised 10 December 2013.

If you weren’t aware, on 4 December 2013, Katie Couric, a fairly popular USA-based journalist with her own eponymous TV talk show, Katie, did a report about Gardasil (formally known as the HPV quadrivalent vaccine and also called Silgard in Europe). Essentially, Couric interviewed several individuals who claim, without any evidence (and lacking any clue about statistical analysis) that Gardasil harmed their children. Couric gave about a minute of time to ONE physician to explain the safety and effectiveness of Gardasil, as opposed to the heartbreaking, but ultimately irrelevant, stories from parents who needed to blame something for what had happened, and chose Gardasil. As opposed to depression, diet soda, bottled water, air pollution, bad TV shows, or that fake butter that the movie theaters use.

As I wrote before, Gardasil is incredibly safe, as shown in massive and well-designed epidemiological studies. It prevents HPV (human papillomavirus) infection, a sexually transmitted disease. And in case you think it’s just some benign virus, HPV is directly responsible for cervical cancer, anal cancer, vulvar cancer, vaginal cancer, oropharyngeal cancer and penile cancer. These are all deadly, disfiguring, and potentially preventable cancers through the use of HPV vaccines.

In other words, Couric, in the ultimate example of false balance–Couric believed that both sides of a scientific “debate” are equivalent in quality of opinion and evidence. But rarely is this true, especially in scientific principles that have been well-studied and supported by a massive amount of evidence. The safety and efficacy of vaccines is supported by the vast consensus of real science. The antivaccination side has no evidence, so it must rely upon logical fallacies and cherry picked data, and lack any real, world-class contingent of scientists who have stepped up to change the consensus with real evidence.Read More »Katie Couric doubles down on the Gardasil false balance

The beginning of the end of Gardasil–probably not

  More fear mongering from the antivaccination forces, this time claiming that “mainstream news media is widely reporting today that a French teenager has filed a lawsuit against French pharmaceutical company, Sanofi Pasteur, and France’s health regulators, over side-effects that were… Read More »The beginning of the end of Gardasil–probably not

HPV incidence

Why we vaccinate – reduction in HPV incidence in UK

The HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe) prevents infection by the human papillomavirus, a sexually transmitted disease. The vaccine specifically targets subtypes 16 and 18, that cause not only approximately 70% of cervical cancers, but also they cause most HPV-induced anal (95%… Read More »Why we vaccinate – reduction in HPV incidence in UK

One-dose HPV-vaccination still works to prevent cancer

The HPV vaccine prevents infection by human papillomavirus, a sexually transmitted disease, specifically subtypes 16 and 18, that not only cause approximately 70% of cervical cancers, but also they cause most HPV-induced anal (95% linked to HPV), vulvar (50% linked), vaginal (65% linked), oropharyngeal (60% linked) and penile (35% linked) cancers. The viruses are… Read More »One-dose HPV-vaccination still works to prevent cancer

The importance of the HPV vaccine to gay men

cover-your-buttMany of us who provide scientific information about HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe), tend to focus on its effects on preventing cancers in women, so articles are inclined to pay attention to vaccinating teenage girls rather than boys. But, if you carefully analyze the disease, human papillomavirus, a sexually transmitted disease, its subtypes 16 and 18 not only cause approximately 70% of cervical cancers, but they cause most HPV-induced anal (95% linked to HPV), vulvar (50% linked), vaginal (65% linked), oropharyngeal (60% linked) and penile (35% linked) cancers. The viruses are generally passed through genital contact, almost always as a result of vaginal, oral and anal sex. 

These HPV-related cancers can be prevented as long as you can prevent the HPV infection itself, either through never having genital contact with an infected person (and since about 79 million adult Americans are infected with the virus, that’s going to be difficult) or the HPV vaccine. The vaccine is a vitally important part of the war against HPV, it prevents the transmission of certain types (pdf) of human papillomavirus (HPV), specifically types 6, 11, 16 and 18. These subtypes of HPV are most often implicated in these cancers.Read More »The importance of the HPV vaccine to gay men

HPV vaccinations lagging despite strong safety and effectiveness

hpvThe CDC recently reported that only about half of US teenager girls have received the safe and effective quadrivalent HPV vaccine (HPV4), a disappointing level of vaccine uptake. Moreover, this rate hasn’t changed over the past three years, despite significant efforts to increase the awareness and effectiveness of the vaccine amongst teenagers. Even worse news in this report is that only about one-third of teenage girls have been fully immunized with all three doses.

HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe), is marketed by Merck & Co., usually for vaccination of teenage girls (with an increasing number of boys). The vaccine prevents the transmission of certain types (pdf) of human papillomavirus (HPV), specifically types 6, 11, 16 and 18. 

HPV types 16 and 18 cause approximately 70% of cervical cancers, and caused most HPV-induced anal (95% linked to HPV), vulvar (50% linked), vaginal (65% linked), oropharyngeal (60% linked) and penile (35% linked) cancers. These cancers, mostly related to HPV, can be prevented as long as you can prevent the HPV infection from ever happening, which usually happens through genital contact, most often during vaginal and anal sex.

HPV may also be passed on during oral sex and genital-to-genital contact. HPV can be passed on between straight and same-sex partners—even when the infected partner has no signs or symptoms. Approximately 79 million Americans, most in their late teens and early 20′s, are infected with HPV, and about 14 million people become infected each year in the USA.Read More »HPV vaccinations lagging despite strong safety and effectiveness

Study shows HPV vaccine lowers HPV infection risk in teen girls

conservative-HPV-vaccineHPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe), is marketed by Merck, usually for vaccination of teenage girls (with an increasing number of boys). The vaccine prevents the transmission of certain types (pdf) of human papillomavirus (HPV), specifically types 6, 11, 16 and 18. HPV types 16 and 18 cause approximately 70% of cervical cancers, and caused most HPV-induced anal (95% linked to HPV), vulvar (50% linked), vaginal (65% linked), oropharyngeal (60% linked) and penile (35% linked) cancers. These cancers, mostly related to HPV, can be prevented as long as you can prevent the HPV infection from ever happening, which usually happens through genital contact, most often during vaginal and anal sex. HPV may also be passed on during oral sex and genital-to-genital contact. HPV can be passed on between straight and same-sex partners—even when the infected partner has no signs or symptoms. Approximately 79 million Americans, most in their late teens and early 20’s, are infected with HPV, and about 14 million people become infected each year in the USA.Read More »Study shows HPV vaccine lowers HPV infection risk in teen girls

Vaccines saves lives–HPV scientific evidence part 2

 

© Copyright CSL, 2013. All Rights Reserved.
© Copyright CSL, 2013. All Rights Reserved.

Human papillomavirus (HPV) is a virus from the papillomavirus family that is capable of infecting humans. Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes, making it easily transmitted sexually or through other intimate contact. While the majority of the known types of HPV cause no symptoms in most people, some types can cause warts (verrucae). HPV types 16 and 18 cause approximately 70% of cervical cancers, and cause most HPV-induced anal, vulvar, vaginal, and penile cancers. The HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe), is marketed by Merck. The vaccine prevents the transmission of certain types of HPV, specifically types 6, 11, 16 and 18. 

 

 

 

 

 

Read More »Vaccines saves lives–HPV scientific evidence part 2

HPV–early vaccination maximizes effectiveness

 

HPV protesters in Texas.

Human papillomavirus (HPV) is a virus from the papillomavirus family that is capable of infecting humans. Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes, making it easily transmitted sexually or through other intimate contact. While the majority of the known types of HPV cause no symptoms in most people, some types can cause warts (verrucae). HPV types 16 and 18 cause approximately 70% of cervical cancers, and cause most HPV-induced anal, vulvar, vaginal, and penile cancers. The HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe), is marketed by Merck. The vaccine prevents the transmission of certain types of HPV, specifically types 6, 11, 16 and 18. 

Although the safety of HPV vaccine has been thoroughly vetted for safety in studies with large cohorts, the long time period (up to decades) from infection to a diagnosis of an HPV-related cancer has left questions about how to maximize effectiveness of the vaccine which required further research. Read More »HPV–early vaccination maximizes effectiveness